A
Anja Feldmann
Researcher at Max Planck Society
Publications - 368
Citations - 18932
Anja Feldmann is an academic researcher from Max Planck Society. The author has contributed to research in topics: The Internet & Antigen. The author has an hindex of 67, co-authored 340 publications receiving 17422 citations. Previous affiliations of Anja Feldmann include Saarland University & AT&T.
Papers
More filters
Book ChapterDOI
The Internet Architecture - Is a Redesign Needed?
TL;DR: The Internet realizes William Gibsons vision of Cyberspace: “A consensual hallucination experienced daily by billions of legitimate operators, in every nation”.
Towards meticulous data plane monitoring
TL;DR: There is a need for a meticulous data plane monitoring tool to check all of the flow rules and links for possible faults and localize them.
BookDOI
Passive and Active Measurement
TL;DR: FADER is created, a new algorithm that can identify rate limiting from user-side traces with minimal new measurement traffic and it is suggested that fall-off in responses as rates approach 1 packet/s per /24 block is consistent with rate limiting.
Journal ArticleDOI
Nanosensors in clinical development of CAR-T cell immunotherapy.
Trang Anh Nguyen-Le,Tabea Bartsch,Robert Wodtke,Florian Brandt,Claudia Arndt,Anja Feldmann,Diana Isabel Sandoval Bojorquez,Arnau Perez Roig,Bergoi Ibarlucea,Seungho Lee,Chank-Ki Baek,Gianaurelio Cuniberti,Ralf Bergmann,Edinson Puentes-Cala,Javier Andrés Soto,Biji T. Kurien,Michael Bachmann,Larysa Baraban +17 more
TL;DR: In this article , silicon nanowire field-effect transistors are used to develop target modules for an optimized CAR-T cell operation, and the CAR T-cells redirection capability of selected peptides in target modules was proven successful in an in-vitro cytotoxicity assay.
Journal ArticleDOI
Development of Novel Anti-CD10 Target Modules for Redirection of Universal CAR T Cells Against CD10-Positive Malignancies
Anja Feldmann,Stefanie Koristka,Claudia Arndt,Liliana Raquel Loureiro,Liliana Raquel Loureiro,Ralf Bergmann,Nicole Berndt,Anja Hoffmann,Justyna Jureczek,Nicola Mitwasi,Martin Bornhaeuser,Václav Hořejší,Michael Bachmann +12 more
TL;DR: A novel anti-CD10 TM was constructed which is able to redirect UniCAR T cells to eliminate CD10-expressing tumor cells and establish a universal, switchable, modular and universal UniCAR platform technology that can be used to targetCD10-positive malignancies.